Ben S. Cooper
Impact in
-
- Antibiotic Use and Resistance
- Modeling and Simulation top 0.1%
- COVID-19 epidemiological studies
Papers in
-
- Antimicrobial Resistance in Staphylococcus 27
- Infection Control in Healthcare 12
- Epidemiology 23
- Pneumonia and Respiratory Infections 6
- Co-authors
- Graham F. Medley (10 shared papers)B. Cookson (15 shared papers)Marc Lipsitch (5 shared papers)S. Stone (9 shared papers)Shah Ebrahim (6 shared papers)C C Kibbler (6 shared papers)Nicholas Day (20 shared papers)Lyn James (1 shared paper)
- Journals
- PLoS Medicine (10 papers)Journal of Hospital Infection (9 papers)Clinical Infectious Diseases (8 papers)PLoS ONE (6 papers)Journal of Antimicrobial Chemotherapy (6 papers)
- Partner nations
- United KingdomThailandUnited States
In The Last Decade
Ben S. Cooper
149 papers receiving 7.9k citations
Ben S. Cooper's Hit Papers
Peers
Comparison fields: 5 of 188
- Applied Microbiology and Biotechnology 737
- Modeling and Simulation 1.3k
- Infectious Diseases 3.0k
- Molecular Medicine 781
- Clinical Biochemistry 661
Countries citing papers authored by Ben S. Cooper
This map shows the geographic impact of Ben S. Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ben S. Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ben S. Cooper more than expected).
Fields of papers citing papers by Ben S. Cooper
This network shows the impact of papers produced by Ben S. Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ben S. Cooper. The network helps show where Ben S. Cooper may publish in the future.
Co-authors
The 25 scholars most cited alongside Ben S. Cooper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 152 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Transmission Dynamics and Control of Severe Acute Respiratory Syndrome Hit paper breakdown → | 2003 | 1009 |
| 2 | 2004 | 245 | |
| 3 | 2000 | 236 | |
| 4 | 2007 | 235 | |
| 5 | 2009 | 235 | |
| 6 | 2006 | 234 | |
| 7 | 2005 | 224 | |
| 8 | 2015 | 220 | |
| 9 | 2004 | 208 | |
| 10 | 2014 | 192 | |
| 11 | 2018 | 187 | |
| 12 | 2003 | 186 | |
| 13 | 2012 | 173 | |
| 14 | 2009 | 167 | |
| 15 | 2012 | 165 | |
| 16 | 2011 | 156 | |
| 17 | 2007 | 153 | |
| 18 | 1967 | 137 | |
| 19 | 2014 | 129 | |
| 20 | 2011 | 125 |
About Ben S. Cooper
Ben S. Cooper is a scholar working on Infectious Diseases, Epidemiology, Applied Microbiology and Biotechnology, Molecular Medicine and Critical Care and Intensive Care Medicine, having authored 152 papers that have together received 8.2k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (27 papers), Antibiotic Use and Resistance (17 papers), Antibiotic Resistance in Bacteria (15 papers), Infection Control in Healthcare (12 papers), COVID-19 epidemiological studies (10 papers), Bacterial Identification and Susceptibility Testing (10 papers), Nosocomial Infections in ICU (10 papers) and Pneumonia and Respiratory Infections (6 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (737 citations), Modeling and Simulation (1.3k citations), Infectious Diseases (3.0k citations), Molecular Medicine (781 citations) and Clinical Biochemistry (661 citations). Ben S. Cooper has collaborated with scholars based in United Kingdom, Thailand and United States. Frequent co-authors include Graham F. Medley, B. Cookson, Marc Lipsitch, S. Stone, Shah Ebrahim, C C Kibbler, Nicholas Day, Lyn James, Suok Kai Chew and Megan Murray. Their work appears in journals such as PLoS Medicine, Journal of Hospital Infection, Clinical Infectious Diseases, PLoS ONE and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.